0001638599-19-000583.txt : 20190531 0001638599-19-000583.hdr.sgml : 20190531 20190531161919 ACCESSION NUMBER: 0001638599-19-000583 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190401 FILED AS OF DATE: 20190531 DATE AS OF CHANGE: 20190531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kay Robert CENTRAL INDEX KEY: 0001285612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35023 FILM NUMBER: 19870717 MAIL ADDRESS: STREET 1: C/O IBIO, INC. STREET 2: 9 INNOVATION WAY, SUITE 100 CITY: NEWARK STATE: DE ZIP: 19711 FORMER NAME: FORMER CONFORMED NAME: KAY ROBERT DATE OF NAME CHANGE: 20040331 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iBio, Inc. CENTRAL INDEX KEY: 0001420720 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262797813 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 600 MADISON AVENUE, SUITE 1601 CITY: NEW YORK STATE: NY ZIP: 10022-1737 BUSINESS PHONE: 302 355-0650 MAIL ADDRESS: STREET 1: 600 MADISON AVENUE, SUITE 1601 CITY: NEW YORK STATE: NY ZIP: 10022-1737 FORMER COMPANY: FORMER CONFORMED NAME: iBioPharma, Inc. DATE OF NAME CHANGE: 20080806 FORMER COMPANY: FORMER CONFORMED NAME: InB:Biotechnologies, Inc. DATE OF NAME CHANGE: 20071210 4 1 doc4_6097.xml PRIMARY DOCUMENT X0306 4 2019-04-01 0 0001420720 iBio, Inc. IBIO 0001285612 Kay Robert C/O IBIO, INC. 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022 1 1 0 0 Executive Chairman and CEO Stock Option (right to buy) 0.90 2019-04-01 4 A 0 50000 0.90 A 2020-04-01 2029-04-01 Common Stock 50000 357500 D /s/ Robert B. Kay 2019-05-31